Sorrento Publishes an Abivertinib Teaser Entitled “Abivertinib – A Franchise Oral Therapeutic for Cancer, COVID-19 and Autoimmune Diseases”

Sorrento Publishes an Abivertinib Teaser Entitled “Abivertinib – A Franchise Oral Therapeutic for Cancer, COVID-19 and Autoimmune Diseases”

Sorrento Publishes an Abivertinib Teaser Entitled “Abivertinib – A Franchise Oral Therapeutic for Cancer, COVID-19 and Autoimmune Diseases”
Lefamulin NDA Filed in Mainland China for Treatment of Community Acquired Pneumonia
CohBar’s CEO to Participate in Upcoming BIO Webinar
Revelation Biosciences Inc. Announces Creation and Appointments to Scientific Advisory Board
Todos Medical Enters into Binding Agreement to Acquire All 3CL Protease Biology-Related Assets and Intellectual Property from NLC Pharma
Tauriga Sciences Inc. Generates Record Weekly Net E-Commerce Sales
COVID Vaccine  Eat This Not That

COVID Vaccine Eat This Not That

November 29, 2021

Experts warn about the mistakes people make with the COVID-19 vaccine. ETNT Health. Sure Signs You've Caught COVID After Your Vaccine. You may have a "breakthrough" case of COVID-19 and these are the signs. ETNT Health. Doctors Say "Do Not" Do This After Your COVID Booster.

Continue reading here:
COVID Vaccine Eat This Not That
KDHE Vaccine KS | Official Website

KDHE Vaccine KS | Official Website

November 29, 2021

Rumors and scams can easily circulate in times of crisis. Do your part to the stop the spread of misinformation and protect Kansans by relying on trusted sources of information.Learn more about how to protect yourself and your loved ones from the latest COVID-19 scams.


The rest is here:
KDHE Vaccine KS | Official Website
Moderna says its COVID-19 vaccine protective, safe in …

Moderna says its COVID-19 vaccine protective, safe in …

November 29, 2021

A healthcare worker holds a vial of the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar//File Photo

Register

Oct 25 (Reuters) - Moderna Inc (MRNA.O) said on Monday its COVID-19 vaccine generated a strong immune response in children aged six to 11 years and that it plans to submit the data to global regulators soon.

Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults. It cited interim data that has yet to be peer reviewed.

It was unclear when U.S. regulators will weigh in on the shot. The Moderna COVID-19 vaccine is authorized for adults over the age of 18 years and is waiting for a response to its June application for children aged 12 through 17.

Register

It is behind rivals Pfizer Inc (PFE.N) and BioNTech SE , whose vaccine has been authorized for ages 12 and up since May. A panel of outside advisers to the U.S. Food and Drug Administration will meet on Tuesday to decide whether to recommend Pfizer's vaccine in children aged five to 11 years.

Moderna said that in its trial of 4,753 participants, side effects were mostly mild to moderate in severity. The most common side effects were fatigue, headache, fever and injection site pain.

The company statement did not disclose any new information about cases of heart inflammation called myocarditis, a known side effect of mRNA vaccines.

The shots were 50 microgram doses, half the strength used in the primary vaccine series for adults and the same as the booster dose authorized for adults. It is higher than the 10 microgram dose Pfizer is planning for its vaccine in children.

Both the Moderna and Pfizer/BioNTech vaccines have been linked to myocarditis in young men.

Some studies have suggested the rate of incidence in recipients of the Moderna vaccine may be higher than in Pfizer recipients, perhaps because of the stronger dose of vaccine.

Sweden has paused the use of the Moderna vaccine for younger age groups because of the higher risk of myocarditis.

While children rarely become seriously ill or die from COVID-19, some do develop rare complications, and COVID-19 cases in unvaccinated children have risen due to the contagious Delta variant.

Children can also spread the virus, infecting those who are not protected by vaccines and giving the virus more room to develop new variations.

Moderna shares rose 2% in morning trading.

Register

Reporting by Manas Mishra in Bengaluru and Michael Erman in New Jersey; Editing by Shounak Dasgupta and Howard Goller

Our Standards: The Thomson Reuters Trust Principles.


See original here:
Moderna says its COVID-19 vaccine protective, safe in ...
Covid-19 Vaccine Makers Assess Omicron Response – The Wall Street Journal

Covid-19 Vaccine Makers Assess Omicron Response – The Wall Street Journal

November 29, 2021

We are delighted that you'd like to resume your subscription.

You will be charged $ + tax (if applicable) for The Wall Street Journal. You may change your billing preferences at any time in the Customer Center or call Customer Service. You will be notified in advance of any changes in rate or terms. You may cancel your subscription at anytime by calling Customer Service.

Please click confirm to resume now.


More: Covid-19 Vaccine Makers Assess Omicron Response - The Wall Street Journal